Potential and challenges of serotherapy for severe influenza

The Lancet Respiratory Medicine

Volumn 5, Issue 8, 2017, Pages e27-

  Lee, Nelson ^a   Hui, David S C ^a  

^a Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; ANTIVIRUS AGENT; HEMAGGLUTINATION INHIBITING ANTIBODY; HYPERIMMUNE GLOBULIN; MONOCLONAL ANTIBODY; SIALIDASE INHIBITOR;

ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY TITER; AVIAN INFLUENZA (H5N1); BLOOD CLOTTING DISORDER; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNE MEDIATED INJURY; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION RISK; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H7N9); LETTER; NONHUMAN; PRIORITY JOURNAL; SEROTHERAPY; SEVERE ACUTE RESPIRATORY SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; PASSIVE IMMUNIZATION;

HUMANS; IMMUNIZATION, PASSIVE; INFLUENZA, HUMAN;

EID: 85025120038     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30266-7     Document Type: Letter

References (6)

1. Beigel, JH, Tebas, P, Elie-Turenne, MC, et al., IRC002 Study Team. Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study. Lancet Respir Med 5 (2017), 500–511.
2. Hui, DS, Lee, N, Chan, PK, Adjunctive therapies and immunomodulatory agents in the management of severe influenza. Antiviral Res 98 (2013), 410–416.
3. Lee, N, Leo, YS, Cao, B, et al. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J 45 (2015), 1642–1652.
4. Banoei, MM, Vogel, HJ, Weljie, AM, et al., Canadian Critical Care Translational Biology Group (CCCTBG). Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia. Crit Care, 21, 2017, 97.
5. Lee, N, Wong, CK, Chan, MCW, et al. Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial. Antiviral Res 144 (2017), 48–56.
6. Corti, D, Cameroni, E, Guarino, B, Kallewaard, NL, Zhu, Q, Lanzavecchia, A, Tackling influenza with broadly neutralizing antibodies. Curr Opin Virol 24 (2017), 60–69.